Are there any contraindications or precautions dermatologists should consider before beginning a patient on ruxolitinib for vitiligo?

Featuring Benjamin Lockshin, MD | EVP of Strategic InitiativesDirector of the Clinical Trials CenterAssistant ProfessorUS Dermatology PartnersGeorgetown UniversityRockville, MD | Published July 01, 2024